Remote Patient Monitoring Tied to Better Dialysis Technique Survival
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 23, 2024 -- Remote patient monitoring (RPM) may improve technique survival in patients on automated peritoneal dialysis (APD), according to a study published in the February issue of Kidney International Reports.
Francisco Javier Centellas-Pérez, from Albacete General University Hospital in Spain, and colleagues evaluated the association between the use of RPM and clinical outcomes in patients on APD. The analysis included 176 APD patients with RPM and 56 without RPM.
The researchers found that RPM was associated with a lower mortality rate (hazard ratio [HR], 0.08) and greater technique survival rate (hazard ratio, 0.25). Even after a propensity score-matched analysis, RPM continued to be associated with better technique survival (hazard ratio, 0.23).
"The current study agreed that RPM may improve technique survival. This improvement in PD survival may be mainly due to an improvement in adherence, although due to the characteristics of this study, this fact cannot be demonstrated," the authors write. "Therefore, there would be increasing probability of identifying mechanical problems at early stages, which is a key goal of this type of therapy."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Risk for Kidney Complications Increased After Heart Failure Hospitalization
WEDNESDAY, June 5, 2024 -- Older adults with heart failure have considerable risk for kidney complications, with 6 percent progressing to dialysis at one year after...
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.